Neal J Meropol Selected Research

Neal J Meropol Research Topics

Disease

69	Neoplasms (Cancer) 04/2024 - 05/2002
30	Colorectal Neoplasms (Colorectal Cancer) 07/2023 - 01/2003
12	Adenocarcinoma 01/2021 - 01/2003
11	Carcinoma (Carcinomatosis) 01/2020 - 01/2003
9	Fatigue 04/2024 - 10/2002
9	Rectal Neoplasms (Rectal Cancer) 01/2022 - 12/2005
8	Pancreatic Neoplasms (Pancreatic Cancer) 01/2016 - 01/2002
7	Neutropenia 04/2024 - 10/2002
7	Esophageal Neoplasms (Esophageal Cancer) 01/2019 - 02/2006
6	Breast Neoplasms (Breast Cancer) 04/2024 - 12/2002
6	Diarrhea 01/2020 - 07/2002
4	Vomiting 07/2023 - 04/2003
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2020 - 01/2009
4	Colonic Neoplasms (Colon Cancer) 01/2020 - 12/2012
3	Hypertension (High Blood Pressure) 04/2024 - 04/2007
3	Neoplasm Metastasis (Metastasis) 01/2018 - 07/2005
3	Pathologic Complete Response 03/2012 - 02/2006
3	Disease Progression 09/2007 - 01/2003
2	Hemorrhage 07/2023 - 04/2007
2	Pain (Aches) 01/2020 - 01/2019
2	Leukopenia 01/2020 - 12/2009
2	Death (Near-Death Experience) 01/2019 - 01/2019
2	Microsatellite Instability 01/2018 - 03/2004
2	Renal Cell Carcinoma (Grawitz Tumor) 11/2017 - 12/2015
2	Cardiotoxicity 10/2013 - 07/2012
2	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2012 - 07/2008
2	Mucositis 01/2009 - 04/2003
2	Thrombocytopenia (Thrombopenia) 01/2009 - 04/2003
2	Fibrosis (Cirrhosis) 08/2008 - 01/2003
2	Leukemia 07/2008 - 12/2002
2	Fever (Fevers) 04/2007 - 12/2002
1	Left Ventricular Dysfunction 04/2024
1	Melanoma (Melanoma, Malignant) 01/2020
1	Urinary Bladder Neoplasms (Bladder Cancer) 10/2019
1	Primitive Neuroectodermal Tumors (PNET) 01/2018
1	Liver Diseases (Liver Disease) 01/2018

Drug/Important Bio-Agent (IBA)

14	Bevacizumab (Avastin)FDA Link 04/2024 - 01/2003
13	Fluorouracil (Carac)FDA LinkGeneric 07/2023 - 07/2002
12	Irinotecan (Camptosar)FDA LinkGeneric 07/2023 - 10/2002
11	Oxaliplatin (Eloxatin)FDA LinkGeneric 07/2023 - 02/2004
10	Capecitabine (Xeloda)FDA Link 11/2020 - 02/2004
9	ErbB Receptors (EGF Receptor)IBA 09/2014 - 11/2003
7	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 01/2005
7	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2012 - 01/2003
6	Leucovorin (Folinic Acid)FDA Link 07/2023 - 01/2003
5	Biomarkers (Surrogate Marker)IBA 01/2021 - 03/2009
5	Cetuximab (Erbitux)FDA Link 12/2012 - 04/2004
5	Proteins (Proteins, Gene)FDA Link 03/2011 - 04/2003
4	Trastuzumab (Herceptin)FDA Link 04/2024 - 12/2002
4	Panitumumab (Vectibix)FDA Link 12/2012 - 09/2007
3	Carboplatin (JM8)FDA LinkGeneric 01/2020 - 01/2019
3	Immune Checkpoint InhibitorsIBA 01/2020 - 01/2019
3	Thymidylate SynthaseIBA 01/2018 - 02/2005
3	Sunitinib (Sutent)FDA Link 01/2018 - 07/2008
3	Docetaxel (Taxotere)FDA Link 05/2015 - 01/2005
3	Gemcitabine FDA Link 10/2014 - 02/2011
3	AntibodiesIBA 09/2014 - 03/2007
2	human ERBB2 proteinIBA 04/2024 - 01/2021
2	Dihydrotachysterol (AT 10)IBA 07/2023 - 04/2007
2	Glutamine (L-Glutamine)FDA Link 11/2020 - 01/2016
2	Indicators and Reagents (Reagents)IBA 01/2019 - 04/2004
2	Transaminases (Aminotransferases)IBA 01/2016 - 02/2008
2	Bortezomib (Velcade)FDA Link 06/2014 - 02/2008
2	Proteasome InhibitorsIBA 06/2014 - 02/2008
2	Insulin (Novolin)FDA Link 10/2013 - 07/2009
2	Cytotoxins (Cytolysins)IBA 10/2012 - 11/2003
2	ChemokinesIBA 03/2011 - 03/2007
2	Glucose (Dextrose)FDA LinkGeneric 07/2009 - 05/2009
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2009 - 02/2006
2	Fibroblast Growth Factor 7 FDA Link 01/2009 - 04/2003
2	ParaffinIBA 08/2008 - 04/2004
2	Antineoplastic Agents (Antineoplastics)IBA 09/2007 - 04/2003
2	Farnesyltranstransferase (Farnesyltransferase)IBA 06/2004 - 04/2003
2	tipifarnib (R115777)IBA 06/2004 - 04/2003
1	Temozolomide (Temodar)FDA LinkGeneric 01/2021
1	methoxyamineIBA 01/2021
1	Drug CombinationsIBA 01/2021
1	GlutaminaseIBA 11/2020
1	CB-839IBA 11/2020
1	TabletsIBA 01/2020
1	afliberceptIBA 01/2019
1	Genetic Markers (Genetic Marker)IBA 01/2019
1	cyclopropapyrroloindoleIBA 01/2019
1	Pemetrexed (MTA)FDA Link 01/2019
1	antineoplaston A10 (A 10)IBA 01/2018

Therapy/Procedure

45	Therapeutics 07/2023 - 01/2002
26	Drug Therapy (Chemotherapy) 04/2024 - 01/2003
9	Radiotherapy 09/2016 - 04/2007
7	Chemoradiotherapy 12/2012 - 02/2006
6	Neoadjuvant Therapy 01/2020 - 01/2003
3	Immunotherapy 10/2019 - 09/2010
2	Combined Modality Therapy 01/2022 - 07/2008
2	Esophagectomy 01/2019 - 12/2012
2	Lymph Node Excision (Lymph Node Dissection) 01/2019 - 12/2002
2	Nephrectomy 11/2017 - 12/2015
2	Adjuvant Chemotherapy 07/2014 - 12/2012
1	Secondary Prevention 01/2020
1	Colostomy 01/2020
1	Behavior Control 12/2019
1	Epidural Analgesia 01/2019